Pharmacological management of osteoarthritis: Position statement of the Indian Orthopaedic Rheumatology Association

References

1. Sanchez-Dopazo R, Rathod M, Shandilya A, Vala J, Kalra E, Giri T et al. Statewide burden of osteoarthritis In India and its trend from 1990-2021: A benchmarking analysis. Arthritis Rheumatol. 2024;76(suppl 9):1880.
2. Kandasamy S, Vadivelu R, Shanmugam S, Mahendran BS. Exploring the burden of knee osteoarthritis in rural south India: Community prevalence, risk factors, and functional assessment among adults aged 40 and above. Cureus. 2024;16(11):e73452.
3. Yadav R, Verma AK, Uppal A, Chahar HS, Patel J, Pal CP. Prevalence of primary knee osteoarthritis in the urban and rural population in India. Indian J Rheumatol. 2022;17(3):239–43.
4. Levens BJ, Kamara E, Hansen E. Osteoarthritis. In: Hansen E, Kühn KD. (eds) Essentials of Cemented Knee Arthroplasty. Springer, Berlin, Heidelberg. 2022
5. Swain S, Sarmanova A, Coupland C, Doherty M, Zhang W. Comorbidities in osteoarthritis: A systematic review and meta‐ analysis of observational studies. Arthritis Care Res. 2019;72(7):991–1000.
6. Marshall DA, Liu X, Barnabe C, Yee K, Faris PD, Barber C et al. Existing comorbidities in people with osteoarthritis: a retrospective analysis of a population-based cohort in Alberta, Canada. BMJ Open. 2019;9(11):e033334.
7. Pati S, MacRae C, Henderson D, Weller D, Guthrie B, Mercer S. Defining and measuring complex multimorbidity: A critical analysis. Br J Gen Pract. 2023;73(733):373-6.
8. Richard MJ, Driban JB, McAlindon TE. Pharmaceutical treatment of osteoarthritis. Osteoarthr Cartilage. 2022;31(4):458–66. Khanna et al. / IP International Journal of Orthopaedic Rheumatology 2025;11(1):4-16 15
9. Maqbool M, Fekadu G, Jiang X, Bekele F, Tolossa T, Turi E et al. An up to date on clinical prospects and management of osteoarthritis. Ann Med Surg. 2021;72(72):103077.
10. Colletti A, Cicero AFG. Nutraceutical approach to chronic osteoarthritis: From molecular research to clinical evidence. Int J Mol Sci. 2021;22(23):12920.
11. Conaghan PG, Arden N, Avouac B, Migliore A, Rizzoli R. Safety of paracetamol in osteoarthritis: What does the literature say? Drugs Aging. 2019;36(S1):7-14.
12. Anderson BJ. Paracetamol (acetaminophen): Mechanisms of action. Pediatr Anesth. 2018;18(10):915–21.
13. National Institute for Health and Care excellence. Osteoarthritis in over 16s: diagnosis and management. 2022.
14. Kolasinski SL, Neogi T, Hochberg MC, Oatis C, Guyatt G, Block J et al. 2019 American College of Rheumatology/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Rheum. 2020;72(2):220–33.
15. Machado GC, Maher CG, Ferreira PH, Pinheiro MB, Lin CW, Day RO et al. Efficacy and safety of paracetamol for spinal pain and osteoarthritis: Systematic review and meta-analysis of randomised placebo controlled trials. BMJ. 2015;350:h1225.
16. Cao Z, Han K, Lu H, Illangamudalige S, Shaheed CA, Chen L et al. Paracetamol combination therapy for back pain and osteoarthritis: A systematic review and meta-analyses. Drugs. 2024;84(8):953–67.
17. Leopoldino AO, Machado GC, Ferreira PH, Pinheiro MB, Day R, McLachlan AJ et al. Paracetamol versus placebo for knee and hip osteoarthritis. Cochrane Database Syst Rev. 2019;2(2):CD013273.
18. Cooper C, Chapurlat R, Al-Daghri N, Herrero-Beaumont G, Bruyère O, Rannou F et al. Safety of oral non-selective non-steroidal anti-inflammatory drugs in osteoarthritis: What does the literature say? Drugs Aging. 2019;36(S1):15–24.
19. da Costa BR, Reichenbach S, Keller N, Nartey L, Wandel S, Jüni P et al. Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta- analysis. Lancet. 2017;390(10090):e21–33.
20. Costa BR da, Pereira TV, Saadat P, Rudnicki M, Iskander SM, Bodmer NS et al. Effectiveness and safety of non-steroidal anti- inflammatory drugs and opioid treatment for knee and hip osteoarthritis: Network meta-analysis. BMJ. 2021;375:n2321.
21. Pelletier JP, Martel-Pelletier J, Rannou F, Cooper C. Efficacy and safety of oral NSAIDs and analgesics in the management of osteoarthritis: Evidence from real-life setting trials and surveys. Semin Arthritis Rheum. 2016;45(4, Supplement):S22–7.
22. Coxib and traditional NSAID Trialists’ (CNT) Collaboration. Vascular and upper gastrointestinal effects of non-steroidal anti- inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet. 2013;382(9894):769–79.
23. Balmaceda C. Clinical trial data in support of changing guidelines in osteoarthritis treatment. J Pain Res. 2014;7:211–8.
24. D’Arcy Y, Mantyh P, Yaksh T, Donevan S, Hall J, Sadrarhami M et al. Treating osteoarthritis pain: Mechanisms of action of acetaminophen, nonsteroidal anti-inflammatory drugs, opioids, and nerve growth factor antibodies. Postgrad Med. 2021;133(8):879–
25. Bannuru RR, Osani MC, Vaysbrot EE, Arden NK, Bennell K, Bierma-Zeinstra SMA et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage. 2019;27(11):1578–89.
26. Welsch P, Petzke F, Klose P, Häuser W. Opioids for chronic osteoarthritis pain: An updated systematic review and meta‐analysis of efficacy, tolerability and safety in randomized placebo‐controlled studies of at least 4 weeks double‐blind duration. Eur J Pain. 2020;24(4):685–703.
27. Krebs EE, Gravely A, Nugent S, Jensen AC, DeRonne B, Goldsmith ES et al. Effect of opioid vs nonopioid medications on pain-related function in patients with chronic back pain or hip or knee osteoarthritis pain. J Am Med Assoc. 2018;319(9):872–82.
28. Jiang H, Xing X, Zhu H, Dong T. Adverse effects of opioid analgesics in osteoarthritis treatment: A global meta-analysis, 2000–
29. China CDC Weekly. 2024;6(25):589–96.
30. Reed K, Collaku A, Moreira S. Efficacy and safety of twice daily sustained-release paracetamol formulation for osteoarthritis pain of the knee or hip: A randomized, double-blind, placebo-controlled, twelve-week study. Curr Med Res Opin. 2018;34(4):689–99.
31. Yaligod V, Raj DG, Sharma AB, Swami M, Batra S, Acharya A et al. Dual release paracetamol in osteoarthritis of knee: A randomized controlled clinical trial. J Clin Diagn Res. 2014;8(11):LC11–5.
32. Singh G, Fort JG, Goldstein JL, Levy RA, Hanrahan PS, Bello AE et al. Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study. Am J Med. 2006;119(3):255–66.
33. Babul N, Noveck R, Chipman H, Roth SH, Gana T, Albert K. Efficacy and safety of extended-release, once-daily tramadol in chronic pain: A randomized 12-week clinical trial in osteoarthritis of the knee. J Pain Symptom Manag. 2004;28(1):59–71.
34. Batlle-Gualda E, Román Ivorra J, Martín-Mola E, Carbonell Abelló J, Linares Ferrando LF, Tornero Molina J et al. Aceclofenac vs paracetamol in the management of symptomatic osteoarthritis of the knee: A double-blind 6-week randomized controlled trial. Osteoarthritis Cartilage. 2007;15(8):900–8.
35. Verkleij SP, Luijsterburg PA, Willemsen SP, Koes BW, Bohnen AM, Bierma-Zeinstra SM. Effectiveness of diclofenac versus paracetamol in knee osteoarthritis: A randomised controlled trial in primary care. Br J Gen Pract. 2015;65(637):e530–7.
36. Smith SR, Deshpande BR, Collins JE, Katz JN, Losina E. Comparative pain reduction of oral non-steroidal anti-inflammatory drugs and opioids for knee osteoarthritis: Systematic analytic review. Osteoarthritis Cartilage. 2016;24(6):962–72.
37. Zhu X, Sang L, Wu D, Rong J, Jiang L. Effectiveness and safety of glucosamine and chondroitin for the treatment of osteoarthritis: A meta-analysis of randomized controlled trials. J Ortho Surg Res. 2018;13(1):170.
38. Brito R, Costa D, Dias C, Cruz P, Barros P. Chondroitin sulfate supplements for osteoarthritis: A critical review. Cureus. 2023;15(6):e40192.
39. Fransen M, Agaliotis M, Nairn L, Votrubec M, Bridgett L, Su S et al. Glucosamine and chondroitin for knee osteoarthritis: A double- blind randomised placebo-controlled clinical trial evaluating single and combination regimens. Ann Rheum Dis. 2014;74(5):851–8.
40. National Institute for Health and Care Excellence. Overview | Osteoarthritis in over 16s: diagnosis and management | Guidance | NICE [Internet]. www.nice.org.uk. 2022. Available from: http://www.nice.org.uk/guidance/ng226
41. Rabade A, Viswanatha GL, Nandakumar K, Kishore A. Evaluation of efficacy and safety of glucosamine sulfate, chondroitin sulfate, and their combination regimen in the management of knee osteoarthritis: a systematic review and meta-analysis. Inflammopharmacology. 2024;32(3):1759–75.
42. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Statement on the safety of glucosamine for patients receiving coumarin anticoagulants. EFSA Journal. 2011;9(12):2473.
43. Marshall PD, Poddar S, Tweed EM, Brandes L. Clinical inquiries: Do glucosamine and chondroitin worsen blood sugar control in diabetes? J Fam Pract. 2006;55(12):1091–3.
44. Central Drugs Standard Control Organization. BAnned drugs list (FDCs) dated 02.8.2024 [Internet]. 2024 [cited 2025 Jan 15]. Available from: https://www.goa.gov.in/wp- content/uploads/2024/08/FDC-DRUGS-BANNED.pdf
45. Martínez-Puig D, Costa-Larrión E, Rubio-Rodríguez N, Gálvez- Martín P. Collagen supplementation for joint health: The link between composition and scientific knowledge. Nutrients. 2023;15(6):1332.
46. Lugo JP, Saiyed ZM, Lane NE. Efficacy and tolerability of an undenatured type II collagen supplement in modulating knee osteoarthritis symptoms: A multicenter randomized, double-blind, placebo-controlled study. Nutrition J. 2015;15(1):14.
47. Crowley DC, Lau FC, Sharma P, Evans M, Guthrie N, Bagchi M et al. Safety and efficacy of undenatured type II collagen in the treatment of osteoarthritis of the knee: A clinical trial. Int J Med Sci. 2009;6(6):312–21. 16 Khanna et al. / IP International Journal of Orthopaedic Rheumatology 2025;11(1):4-16
48. Sadigursky D, Magnavita V, Sa C, De Sousa Monteiro H, Braghiroli O, Matos M. Undenatured collagen type II for the treatment of osteoarthritis of the knee. Acta Ortop Bras. 2022;30(2):e240572.
49. Costa AP, Cunha Teixeira V, Pereira M, Mota Ferreira P, Kuplich PA, Dohnert MB et al. Associated strengthening exercises to undenatured oral type II collagen UCII. A randomized study in patients affected by knee osteoarthritis. Muscle Ligaments Tendons J. 2020;10(03):481.
50. Mehra A, Anand P, Borate M, Paul P, Kamble S, Mehta KD et al. A non-interventional, prospective, multicentric real life Indian study to assess safety and effectiveness of un-denatured type 2 collagen in management of osteoarthritis. Int J Res Orthop. 2019;5(2):315–20.
51. Azeem MA, Patil R. The study of undenatured type II collagen in the knee osteoarthritis. Int J Orthop Traumatol Surgical Sci. 2019;5(1):172–5.
52. Yaramenko O, Fedkov D, Yaramenko K, Comkina M, Mazanko K. Efficacy, tolerance and influence on cartilage metabolism of undenatured collagen type II UC-II TM (Mercana) in knee OA. Pain Joints Spine. 2021;11(3):5–12.
53. Misra D, Booth SL, Tolstykh I, Felson DT, Nevitt MC, Lewis CE et al. Vitamin K deficiency is associated with incident knee osteoarthritis. Am J Med. 2013;126(3):243–8.
54. He Q, Lin Y, Chen B, Chen C, Zeng J, Dou X et al. Vitamin K2 ameliorates osteoarthritis by suppressing ferroptosis and extracellular matrix degradation through activation GPX4’s dual functions. Biomed Pharmacotherapy. 2024;175:116697.
55. Gao XR, Chen YS, Deng W. The effect of vitamin D supplementation on knee osteoarthritis: A meta-analysis of randomized controlled trials. Int J Surg. 2017;46:14–20.
56. Park CY. Vitamin D in the prevention and treatment of osteoarthritis: From clinical interventions to cellular evidence. Nutrients. 2019;11(2):243.
57. Georgescu B, Cristea AE, Oprea D, Lupu AA, Stanciu LE, Borgazi E et al. Current evidence on and clinical implications of vitamin D levels in pain and functional management of knee osteoarthritis: A systematic review. Clinics Pract. 2024;14(5):1997–2012.
58. Jin X, Jones G, Cicuttini F, Wluka A, Zhu Z, Han W et al. Effect of vitamin D supplementation on tibial cartilage volume and knee pain among patients with symptomatic knee osteoarthritis. J Am Med Assoc. 2016;315(10):1005.
59. Arden NK, Cro S, Sheard S, Doré CJ, Bara A, Tebbs SA et al. The effect of vitamin D supplementation on knee osteoarthritis, the VIDEO study: A randomised controlled trial. Osteoarthritis Cartilage. 2016;24(11):1858–66.
60. Sanghi D, Mishra A, Sharma AC, Singh A, Natu SM, Agarwal S et al. Does vitamin D improve osteoarthritis of the knee: A randomized controlled pilot trial. Clin Orthop Relat Res. 2013;471(11):3556–62.
61. McAlindon T, LaValley M, Schneider E, Nuite M, Lee JY, Price LL et al. Effect of vitamin D supplementation on progression of knee pain and cartilage volume loss in patients with symptomatic osteoarthritis. J Am Med Assoc. 2013;309(2):155–62.
62. Zhang FF, Driban JB, Lo GH, Price LL, Booth S, Eaton CB, et al. Vitamin D deficiency is associated with progression of knee osteoarthritis. J Nutr. 2014;144(12):2002–8.
63. Kang SJ, Kim JW, Kim KY, Ku SK, Lee YJ. Protective effects of calcium gluconate on osteoarthritis induced by anterior cruciate ligament transection and partial medial meniscectomy in Sprague– Dawley rats. J Orthop Surg Research. 2014;9(1):14.
64. Li G, Cheng T, Yu X. The impact of trace elements on osteoarthritis. Front Med. 2021;8:771297.
65. Tekeoğlu İ, Şahin MZ, Kamanlı A, Nas K. The influence of zinc levels on osteoarthritis: A comprehensive review. Nutr Res Rev. 2024;23:1–12.
66. Huang TC, Chang WT, Hu YC, Hsieh BS, Cheng HL, Yen JH et al. Zinc protects articular chondrocytes through changes in nrf2- mediated antioxidants, cytokines and matrix metalloproteinases. Nutrients. 2018;10(4):471.
67. Zheng Z, Luo H, Sun C, Xue Q. The influence of zinc and iron intake on osteoarthritis patients’ subchondral sclerosis progression: A prospective observational study using data from the osteoarthritis Initiative. Heliyon. 2023;9(11):e22046-6.
68. Yassin N, El-Shenawy S, Abdel-Rahman R, Yakoot MM, Hassan M, Helmy S. Effect of a topical copper indomethacin gel on inflammatory parameters in a rat model of osteoarthritis. Drug Des Devel Ther. 2015;9:1491–8.
69. Rannou F, Pelletier JP, Martel-Pelletier J. Efficacy and safety of topical NSAIDs in the management of osteoarthritis: Evidence from real-life setting trials and surveys. Semin Arthritis Rheum. 2016;45(4):S18–21.
70. McPherson ML, Cimino NM. Topical NSAID formulations. Pain Med. 2013;14(suppl 1):S35–9.
71. Wang Y, Fan M, Wang H, You Y, Wei C, Liu M et al. Relative safety and efficacy of topical and oral NSAIDs in the treatment of osteoarthritis: A systematic review and meta-analysis. Medicine (Baltimore). 2022;101(36):e30354.
72. Zeng C, Doherty M, Persson MSM, Yang Z, Sarmanova A, Zhang Y et al. Comparative efficacy and safety of acetaminophen, topical and oral non-steroidal anti-inflammatory drugs for knee osteoarthritis: evidence from a network meta-analysis of randomized controlled trials and real-world data. Osteoarthritis Cartilage. 2021;29(9):1242–51.
73. Testa G, Giardina SMC, Culmone A, Vescio A, Turchetta M, Cannavò S et al. Intra-articular injections in knee osteoarthritis: A review of literature. J Funct Morphol Kinesiol. 2021;6(1):15.
74. Tschopp M, Pfirrmann CWA, Fucentese SF, Brunner F, Catanzaro S, Kühne N et al. A randomized trial of intra-articular injection therapy for knee osteoarthritis. Invest Radiol. 2023;58(5):355–62.
75. Huang TL, Chang CC, Lee CH, Chen SC, Lai CH, Tsai CL. Intra- articular injections of sodium hyaluronate (Hyalgan®) in osteoarthritis of the knee. a randomized, controlled, double-blind, multicenter trial in the asian population. BMC Musculoskel Disord. 2011;12(1):221.
76. Hangody L, Szody R, Lukasik P, Zgadzaj W, Lénárt E, Dokoupilova E et al. Intraarticular injection of a cross-linked sodium hyaluronate combined with triamcinolone hexacetonide (Cingal) to provide symptomatic relief of osteoarthritis of the knee: A randomized, double-blind, placebo-controlled multicenter clinical trial. Cartilage. 2017;9(3):276083.
77. Leopold S, Warme W, Pettis P, Shott S. Increased frequency of acute local reaction to intra-articular hylan GF-20 (synvisc) in patients receiving more than one course of treatment. J Bone Joint Surg Am. 2002;84(9):1619–23.
78. Bruyere O, Honvo G, Veronese N, Arden NK, Branco J, Curtis EM et al. An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Semin Arthritis Rheum. 2019;49(3):337–50.